<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01049087</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-112</org_study_id>
    <nct_id>NCT01049087</nct_id>
  </id_info>
  <brief_title>Plasma Volume Determination by 99mTc-labeled Albumin and 125I-labeled Albumin</brief_title>
  <official_title>Comparison of Plasma Volume Determination by 99mTc-labeled Albumin and 125I-labeled Albumin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to compare plasma volume determination by 99mTc-labeled
      albumin with 125I-labeled albumin. Fifteen subjects will be enrolled. The hypothesis is that
      plasma volume determined by the different methods are the same.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For many years, radioiodinated albumin has been &quot;the golden standard&quot; for measurement of
      plasma volume. There are a number of clinical situations in which a nuclide with a shorter
      half-life would be preferred. Furthermore, due to periodic lapses in the availability in the
      delivery of 125I-labeled albumin, there is a need to evaluate another nuclide as a tracer for
      plasma volume determination.

      99mTc-labeled albumin is easily prepared by a simple and reproducible method with a high
      labeling efficiency and short half-life.

      In this study, we want to compare plasma volume determined by 99mTc-labeled albumin with
      plasma volume determined by 125I-albumin (golden standard). In both procedures, plasma volume
      is estimated from multiple postinjection samples for accurate zero-time extrapolation in
      order to correct for leakage of labeled albumin from the vascular compartment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma volume determined by 99mTc-labeled albumin and 125I-labeled albumin</measure>
    <time_frame>January 2011</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of loss of 99mTc-labeled albumin and 125I-labeled albumin from the circulation</measure>
    <time_frame>January 2011</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Plasma volume determination (99mTc-albumin)</intervention_name>
    <description>The test is performed using 5MBq technetium-labeled albumin (99mTc-albumin-Vasculosis) with several postinjection samples for accurate zero-time extrapolation.</description>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Plasma volume determination (125I-albumin)</intervention_name>
    <description>The test is performed using 0.2MBq 125iodine-labeled albumin (125I-albumin) with several postinjection samples for accurate zero-time extrapolation.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt; 27 kg/m2

          -  Written informed consent

        Exclusion Criteria:

          -  Hypertension (140/90 mmHg)

          -  Diabetes mellitus

          -  Any use of medication

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steen Levin, MD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter K Bonfils, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Knud H Stokholm, MD</last_name>
    <role>Study Director</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Koge, Department of Clinical Physiology and Nuclear Medicine</name>
      <address>
        <city>Koge</city>
        <zip>DK-4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2010</study_first_posted>
  <last_update_submitted>March 19, 2013</last_update_submitted>
  <last_update_submitted_qc>March 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2013</last_update_posted>
  <responsible_party>
    <name_title>Peter Kramshoj Bonfils</name_title>
    <organization>University Hospital Koge, Department of Clinical Physiology and Nuclear Medicine</organization>
  </responsible_party>
  <keyword>plasma volume</keyword>
  <keyword>technetium-labeled albumin</keyword>
  <keyword>radioiodine-labeled albumin</keyword>
  <keyword>Healthy volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

